Working… Menu
Trial record 26 of 3537 for:    colon cancer AND Colonic Diseases

Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01294826
Recruitment Status : Completed
First Posted : February 14, 2011
Last Update Posted : June 8, 2015
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Swedish Medical Center

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 2015
Actual Study Completion Date : May 2015